Efficacy and Safety of Fludarabine and Cyclophosphamide Combined Therapy in Patients with Refractory/Recurrent B-Cell Chronic Lymphocytic Leukemia (B-CLL) – Polish Multicentre Study

Reference

• Binet, J.L., Auquier, A., Dighiero, G., Chastang, C., Piguet, H., Goasguen, J., et al. (1981) "A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis", Cancer, 48, 198–206.
   Google Scholar
• Rai, KR., Sawitksy, A., Cronkite, E.P., Chanana, A.D., Levy, R. and Pasternack, B.S. (1975) "Clinical staging of chronic lympho-cytic leukemia", Blood, 46, 219 —234.
   Google Scholar
• Zwiebel, J.A. and Cheson, B.D. (1998) "Chronic lymphocytic leukemia: staging and prognostic factors", Seminars in Oncology, 25, 42–59.
   PubMed Web of Science ®Google Scholar
• Hamblin, T.J., Davis, Z., Gardiner, A., Oscier, D.G. and Stevenson, F.K. (1999) "Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia", Blood, 94, 1848 — 1854.
   Google Scholar
• Damle, R.N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S.L., et al. (1999) "Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia", Blood, 94, 1840–1847.
   Web of Science ®Google Scholar
• Lin, K., Sherrington, P.D., Dennis, M., Matrai, Z., Cawley, J.C. and Pettitt, A.R. (2002) "Relationship between p53 dysfunction, CD38 expression, and IgVH mutation in chronic lymphocytic leukemia", Blood, 100, 1404–1409.
   PubMed Web of Science ®Google Scholar
• Rosenwald, A., Alizadeh, A.A., Widhopf, G., Simon, R., Davis, R.E., Yu, Xin, et al. (2001) "Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia", Journal of Experimental Medicine, 194, 1639 — 1648.
   Web of Science ®Google Scholar
• Orchard, J.A., Ibbotson, R.E., Davis, Z.A., Gardiner, A., Hamblin, T.J. and Oscier, D.G. (2002) "Zap-70 Evaluation by flow cytometry is a significant prognostic marker in B-CLL", Blood, 630 (abstract).
   Google Scholar
• Wiestner, A., Rosenwald, A., Barry, T.S., Wright, G., Davis, R.E., Henrickson, S.E., et al. (2003) "ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglo-bulin genes, inferior clinical outcome, and distinct gene expression profile", Blood, 101, 4944–4951.
   PubMed Web of Science ®Google Scholar
• Crespo, M., Bosch, F., Villamor, N., Bellosillo, B., Colomer, D., Rozman, M., et al. (2003) "ZAP-70 expression as a surrogate for immunoglobulin-variable region mutations in chronic lymphocytic leukemia", New England Journal of Medicine, 348, 1764 — 1775.
   Web of Science ®Google Scholar
• Reinherz, E.L., Kung, P.C., Goldstein, G., Kumagai, M., Coustan-Smith, E. and Murray, D.J. (1980) "Discrete stages of intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T lineage", Proceedings of the National Academy of Sciences of the United States of America, 77, 1588 — 1592.
   Google Scholar
• Malavasi, F., Funaro, A., Roggero, S., Horenstein, A., Calosso, L. and Mehta, K. (1994) "Human CD38: a glycoprotein in search of a function", Immunology Today, 15, 95–97.
   PubMed Web of Science ®Google Scholar
• Oertel, J., Oertel, B., Schliecher, J. and Huhn, D. (1996) "Immunophenotyping of blasts in human bone marrow", Annals in Hematology, 72, 125 — 129.
   PubMed Web of Science ®Google Scholar
• Pascual, V., Liu, Y.J., Magalski, A., de Bouteiller, 0., Banchereau, J. and Capra, J.D. (1994) "Analysis of somatic mutation in five B cell subsets of human tonsil", Journal of Experimental Medicine, 180, 329 — 333.
   Google Scholar
• Jelinek, D.F., Tschumper, R.C., Geyer, S.M., Bone, N.D., Dewald, G.W., Hanson, C.A., et al. (2001) . "Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia", British Journal of Haematology, 115, 854–861.
   PubMed Web of Science ®Google Scholar
• Hamblin, T.J., Orchard, J.A., Ibbotson, R.E., Davis, Z., Thomas, P.W., Stevenson, F.K., et al. (2002) "CD38 expression and immunoglobulin variable region mutations are independent prog-nostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease", Blood, 99, 1023–1029.
   PubMed Web of Science ®Google Scholar
• Mainou-Fowler, T., Dignum, H., Taylor, P.R.A., Dickinson, A., Saunders, P.W.G., Proctor, Si., et al. (2002) "Quantification improves the prognostic value of CD38 expression in B-cell chronic lymphocytic leukaemia", British Journal of Haematology, 118, 755 — 761.
   Google Scholar
• Del Poeta, G., Maurillo, L., Venditti, A., Buccisano, F., Epiceno, A.M., Capelli, G., et al. (2001) "Clinical significance of CD38 expression in chronic lymphocytic leukemia", Blood, 98, 2633 — 2639.
   Google Scholar
• Chevallier, P., Penther, D., Avet-Loiseau, H., Robillard, N., Ifrah, N., Mahe, B., et al. (2002) "CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia", British Journal of Haematology, 116, 142–150.
   PubMed Web of Science ®Google Scholar
• Domingo-Domenech, E., Domingo-Claros, A., Gonzalez-Barca, E., Beneitez, D., Alonso, E., Romagosa, V., et al. (2002) "CD38 expression in B-cell chronic lymphocytic leukaemia: association with clinical presentation and outcome in 155 patients", Haemato-logica, 87, 1021 — 1027.
   Google Scholar
• Dung, J., Naschar, M., Schmucker, U., Renzing-Kohler, K., Holter, T., Huttmann, A., et al. (2002) "CD38 expression is an important prognostic marker in chronic lymphocytic leukemia", Leukemia, 16, 30–35.
   PubMed Web of Science ®Google Scholar
• Ibrahim, S., Keating, M., Do, K.A., O'Brien, S., Huh, Y.O., Jilani, I., et al. (2001) "CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia", Blood, 98, 181–186.
   PubMed Web of Science ®Google Scholar
• Krober, A., Seiler, T., Benner, A., Bullinger, L., Bruckle, E., Lichter, P., et al. (2002) "VH mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia", Blood, 100, 1410— 1416.
   Google Scholar
• Hsi, E.D., Kopecky, K.J., Appelbaum, F.R., Boldt, D., Frey, T., Loftus, M., et al. (2003) "Prognostic significance of CD38 and CD20 expression as assessed by quantitative flow cytometry in chronic lymphocytic leukaemia", British Journal of Haematology, 120, 1017 — 1025.
   Google Scholar
• Gratama, J.W., D'hautcourt, J.L., Mandy, F., Rothe, G., Barnett, D., Janossy, G., et al. (1998) "Flow cytometric quantification of immunolluorescence intensity: problems and perspectives. Eur-opean Working Group on Clinical Cell Analysis", Cytometry, 33, 166 — 178.
   Google Scholar
• Mainou-Fowler, T., Proctor, Si., Miller, S. and Dickinson, A.M. (2001) "Expression and production of interleukin 4 in B-cell chronic lymphocytic leukemia", Leukemia and Lymphoma, 42, 689 — 698.
   Google Scholar
• Ghia, P., Guida, G., Stella, S., Gottardi, D., Geuna, M., Strola, G., et al. (2003) "The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression", Blood, 101, 1262— 1269.
   Google Scholar
• Matrai, Z., Lin, K., Dennis, M., Sherrington, P., Zuzel, M., Pettitt, A.R., et al. (2001) "CD38 expression and VH gene mutation in B-cell chronic lymphocytic leukemia", Blood, 97, 1901–1902.
   Google Scholar
• Morabito, F., Mangiola, M., Oliva, B., Stelitano, C., Callea, V., Deaglio, S., et al. (2001) "Peripheral blood CD38 expression predicts survival in B-cell chronic lymphocytic leukemia", Leukemia Research, 25, 927–932.
   PubMed Web of Science ®Google Scholar